Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects by Shinsuke Hidese

Connect to this object online.

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study by Shinsuke Hidese, Fuyuko Yoshida, Ikki Ishida, Junko Matsuo, Kotaro Hattori, Hiroshi Kunugi

Connect to this object online.

Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorder by Favour Omileke, Sayuri Ishiwata, Junko Matsuo, Fuyuko Yoshida, Shinsuke Hidese, Kotaro Hattori, Hiroshi Kunugi

Connect to this object online.

Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia by Takako Enokida, Kotaro Hattori, Miho Ota, Megumi Tatsumi, Shinsuke Hidese, Noriko Sato, Mikio Hoshino, Hiroshi Kunugi

Connect to this object online.

Gut permeability and its clinical relevance in schizophrenia by Ikki Ishida, Jun Ogura, Emiko Aizawa, Miho Ota, Shinsuke Hidese, Yukihito Yomogida, Junko Matsuo, Sumiko Yoshida, Hiroshi Kunugi

Connect to this object online.

Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study by Shinsuke Hidese, Kotaro Hattori, Kotaro Hattori, Daimei Sasayama, Takuya Tsumagari, Takuya Tsumagari, Tomoko Miyakawa, Ryo Matsumura, Yuuki Yokota, Yuuki Yokota, Ikki Ishida, Junko Matsuo, Sumiko Yoshida, Sumiko Yoshida, Miho Ota, Hiroshi Kunugi, Hiroshi Kunugi

Connect to this object online.